Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: EXTREME LETHARGY; INTERMITTENT FATIGUE; This spontaneous report received from a patient concerned a 56 year old female. The patient''s height, and weight were not reported. The patient''s concurrent conditions included diabetes. The patient experienced nausea and vomiting when treated with sulfamethoxazole/trimethoprim, and itching and swelling when treated with neomycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-APR-2021, the subject experienced extreme lethargy. On 12-APR-2021, the subject experienced intermittent fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from extreme lethargy, and the outcome of intermittent fatigue was not reported. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166